134 related articles for article (PubMed ID: 18438520)
1. Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi.
Makombe SD; Hochgesang M; Jahn A; Tweya H; Hedt B; Chuka S; Yu JK; Aberle-Grasse J; Pasulani O; Bailey C; Kamoto K; Schouten EJ; Harries AD
Bull World Health Organ; 2008 Apr; 86(4):310-4. PubMed ID: 18438520
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
[TBL] [Abstract][Full Text] [Related]
3. Malawi's contribution to "3 by 5": achievements and challenges.
Libamba E; Makombe SD; Harries AD; Schouten EJ; Yu JK; Pasulani O; Mhango E; Aberle-Grasse J; Hochgesang M; Limbambala E; Lungu D
Bull World Health Organ; 2007 Feb; 85(2):156-60. PubMed ID: 17308738
[TBL] [Abstract][Full Text] [Related]
4. Simplifying ART cohort monitoring: can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
Tweya H; Feldacker C; Ben-Smith A; Harries AD; Komatsu R; Jahn A; Phiri S; Tassie JM
BMC Health Serv Res; 2012 Jul; 12():210. PubMed ID: 22818397
[TBL] [Abstract][Full Text] [Related]
5. Improving data quality and supervision of antiretroviral therapy sites in Malawi: an application of Lot Quality Assurance Sampling.
Hedt-Gauthier BL; Tenthani L; Mitchell S; Chimbwandira FM; Makombe S; Chirwa Z; Schouten EJ; Pagano M; Jahn A
BMC Health Serv Res; 2012 Jul; 12():196. PubMed ID: 22776745
[TBL] [Abstract][Full Text] [Related]
6. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
[TBL] [Abstract][Full Text] [Related]
7. Scaling-up antiretroviral therapy in Malawi.
Jahn A; Harries AD; Schouten EJ; Libamba E; Ford N; Maher D; Chimbwandira F
Bull World Health Organ; 2016 Oct; 94(10):772-776. PubMed ID: 27843168
[TBL] [Abstract][Full Text] [Related]
8. Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi.
Libamba E; Makombe S; Mhango E; de Ascurra Teck O; Limbambala E; Schouten EJ; Harries AD
Bull World Health Organ; 2006 Apr; 84(4):320-6. PubMed ID: 16628306
[TBL] [Abstract][Full Text] [Related]
9. National Assessment of Data Quality and Associated Systems-Level Factors in Malawi.
O'Hagan R; Marx MA; Finnegan KE; Naphini P; Ng'ambi K; Laija K; Wilson E; Park L; Wachepa S; Smith J; Gombwa L; Misomali A; Mleme T; Yosefe S
Glob Health Sci Pract; 2017 Sep; 5(3):367-381. PubMed ID: 28963173
[TBL] [Abstract][Full Text] [Related]
10. A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival.
Makombe SD; Jahn A; Tweya H; Chuka S; Yu JK; Hochgesang M; Aberle-Grasse J; Thambo L; Schouten EJ; Kamoto K; Harries AD
PLoS One; 2007 Jul; 2(7):e620. PubMed ID: 17637836
[TBL] [Abstract][Full Text] [Related]
11. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
World Hosp Health Serv; 2008; 44(1):26-9. PubMed ID: 18549031
[TBL] [Abstract][Full Text] [Related]
12. Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of Tanzania.
Kalua T; Tippett Barr BA; van Oosterhout JJ; Mbori-Ngacha D; Schouten EJ; Gupta S; Sande A; Zomba G; Tweya H; Lungu E; Kajoka D; Tih P; Jahn A
J Acquir Immune Defic Syndr; 2017 May; 75 Suppl 1(Suppl 1):S43-S50. PubMed ID: 28398996
[TBL] [Abstract][Full Text] [Related]
13. Early warning indicators for HIV drug resistance in Malawi.
Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
[TBL] [Abstract][Full Text] [Related]
14. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a standardized HIV patient monitoring system in Guyana.
Halpern M; Lachmansingh B; Minior T; Hasbrouck LM; Persaud N; Foo A
Rev Panam Salud Publica; 2010 Aug; 28(2):107-13. PubMed ID: 20963277
[TBL] [Abstract][Full Text] [Related]
16. Strategies for monitoring and evaluation of resource-limited national antiretroviral therapy programs: the two-phase design.
Haneuse S; Hedt-Gauthier B; Chimbwandira F; Makombe S; Tenthani L; Jahn A
BMC Med Res Methodol; 2015 Apr; 15():31. PubMed ID: 25886976
[TBL] [Abstract][Full Text] [Related]
17. Are health workers reduced to being drug dispensers of antiretroviral treatment? A randomized cross-sectional assessment of the quality of health care for HIV patients in northern Uganda.
Seeberger UG; Valadez JJ
Health Policy Plan; 2019 Oct; 34(8):559-565. PubMed ID: 31408152
[TBL] [Abstract][Full Text] [Related]
18. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
J Infect Dev Ctries; 2007 Dec; 1(3):303-7. PubMed ID: 19734609
[TBL] [Abstract][Full Text] [Related]
19. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi.
Harries AD; Schouten EJ; Makombe SD; Libamba E; Neufville HN; Some E; Kadewere G; Lungu D
Bull World Health Organ; 2007 Feb; 85(2):152-5. PubMed ID: 17308737
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Int J Tuberc Lung Dis; 2007 Apr; 11(4):412-6. PubMed ID: 17394687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
